133 related articles for article (PubMed ID: 2476597)
1. Hemodynamic, renal, and hormonal effects of 8-Br-cyclic GMP in conscious dogs with and without congestive heart failure.
Elsner D; Kromer EP; Riegger GA
J Cardiovasc Pharmacol; 1989 Aug; 14(2):241-7. PubMed ID: 2476597
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.
Riegger GA; Elsner D; Kromer EP; Daffner C; Forssmann WG; Muders F; Pascher EW; Kochsiek K
Circulation; 1988 Feb; 77(2):398-406. PubMed ID: 2962788
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 in dogs with heart failure: hemodynamic, hormonal, and renal effects.
Elsner D; Müntze A; Kromer EP; Riegger GA
J Cardiovasc Pharmacol; 1992 Oct; 20(4):547-53. PubMed ID: 1280709
[TBL] [Abstract][Full Text] [Related]
4. Effects of ANP-(95-126) in dogs before and after induction of heart failure.
Riegger GA; Elsner D; Forssmann WG; Kromer EP
Am J Physiol; 1990 Dec; 259(6 Pt 2):H1643-8. PubMed ID: 2175565
[TBL] [Abstract][Full Text] [Related]
5. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic, hormonal, and renal effects of the prostacyclin analogue iloprost in conscious dogs with and without heart failure.
Elsner D; Kromer EP; Riegger AJ
J Cardiovasc Pharmacol; 1990 Oct; 16(4):601-8. PubMed ID: 1706801
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic, renal, and hormonal effects of rapid ventricular pacing in conscious dogs.
Seymour AA; Burkett DE; Asaad MM; Lanoce VM; Clemons AF; Rogers WL
Lab Anim Sci; 1994 Oct; 44(5):443-52. PubMed ID: 7844952
[TBL] [Abstract][Full Text] [Related]
8. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.
Grantham JA; Borgeson DD; Burnett JC
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1077-83. PubMed ID: 9140004
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
Moe GW; Canepa-Anson R; Armstrong PW
J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
[TBL] [Abstract][Full Text] [Related]
10. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic changes and renal plasma flow in early heart failure: implications for renin, aldosterone, norepinephrine, atrial natriuretic peptide and prostacyclin.
Holmer SR; Riegger AJ; Notheis WF; Kromer EP; Kochsiek K
Basic Res Cardiol; 1987; 82(2):101-8. PubMed ID: 2955780
[TBL] [Abstract][Full Text] [Related]
13. Possible regulation of renin release by ANP in dogs with heart failure.
Kanamori T; Wada A; Tsutamoto T; Kinoshita M
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2281-7. PubMed ID: 7611478
[TBL] [Abstract][Full Text] [Related]
14. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
Xu XW; Zeng GY; Yang Y; Liu HX
Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
[TBL] [Abstract][Full Text] [Related]
15. Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep.
Charles CJ; Espiner EA; Richards AM; Nicholls MG; Yandle TG
Am J Physiol; 1995 Jan; 268(1 Pt 2):R201-7. PubMed ID: 7840321
[TBL] [Abstract][Full Text] [Related]
16. Human atrial natriuretic peptide: plasma levels, hemodynamic, hormonal, and renal effects in patients with severe congestive heart failure.
Riegger GA; Kromer EP; Kochsiek K
J Cardiovasc Pharmacol; 1986; 8(6):1107-12. PubMed ID: 2434734
[TBL] [Abstract][Full Text] [Related]
17. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides].
Haloui M; Arnal JF; Pham I; Gonzalez W; Lyoussi B; Michel JB
Ann Endocrinol (Paris); 2000 Feb; 61(1):32-40. PubMed ID: 10790590
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Fennell SA; Cheung HS; Rogers WL
Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758
[TBL] [Abstract][Full Text] [Related]
19. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
[TBL] [Abstract][Full Text] [Related]
20. Intranasal application of atrial natriuretic peptide and 1-deamino-d-arginine vasopressin in healthy volunteers. Hemodynamic, hormonal, and renal excretory effects.
Predel HG; Kuklinski P; Kramer HJ
Am J Hypertens; 1992 Sep; 5(9):657-60. PubMed ID: 1329853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
